Zobrazeno 1 - 8
of 8
pro vyhledávání: '"R. Scott Bermudez"'
Autor:
Min Zhang, Elizabeth H. Hammond, R. Jeffrey Lee, Arnab Chakravarti, R. Scott Bermudez, Alan Pollack, Alex Ho, Li Yan Khor, Michael V. Pilepich, Yoshiyuki Suzuki, William U. Shipley, Howard M. Sandler
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 73:1033-1042
Purpose To examine the prognostic value of nuclear and cytoplasmic survivin expression in men with locally advanced prostate cancer who were enrolled in Radiation Therapy Oncology Group (RTOG) protocol 8610. Methods and Materials RTOG 8610 was a Phas
Autor:
R. Scott Bermudez, Arnab Chakravarti, William U. Shipley, Neelanjan Mukherjee, Douglas E. Latham, Meaghan A. Delaney, Anthony L. Zietman, Min Zhang
Publikováno v:
The Prostate. 64:293-302
BACKGROUND Improvements in the response rates to chemotherapy would represent an important advancement in the care of patients with metastatic prostate cancer. There is accumulating evidence that Survivin, a member of the inhibitor of apoptosis (IAP)
Publikováno v:
Handbook of Evidence-Based Radiation Oncology ISBN: 9780387929873
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae98514f38258044c8ebcecef2c06d4
https://doi.org/10.1007/978-0-387-92988-0_29
https://doi.org/10.1007/978-0-387-92988-0_29
Publikováno v:
Handbook of Evidence-Based Radiation Oncology ISBN: 9780387929873
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fecaf6d18d0fc631dc2c9edbfb5ecdce
https://doi.org/10.1007/978-0-387-92988-0_31
https://doi.org/10.1007/978-0-387-92988-0_31
Publikováno v:
Handbook of Evidence-Based Radiation Oncology ISBN: 9780387929873
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dcb20d4b8bbb4e7356b27a143e9904e
https://doi.org/10.1007/978-0-387-92988-0_14
https://doi.org/10.1007/978-0-387-92988-0_14
Publikováno v:
Handbook of Evidence-Based Radiation Oncology ISBN: 9780387929873
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::198eba011fb4c7235307028de0616be2
https://doi.org/10.1007/978-0-387-92988-0_30
https://doi.org/10.1007/978-0-387-92988-0_30
Publikováno v:
Future oncology (London, England). 3(1)
Four Phase III trials demonstrating higher prostate-specific antigen control rates in prostate cancer patients treated with higher doses of radiation have changed the standard of care. Emerging on-line technologies, improved imaging and computer algo
Autor:
Min Zhang, Neelanjan Mukherjee, R. Scott Bermudez, Douglas E. Latham, Meaghan A. Delaney, Anthony L. Zietman, William U. Shipley, Arnab Chakravarti
Publikováno v:
Prostate; Aug2005, Vol. 64 Issue 3, p293-302, 10p